Epigenetics of hepatocellular carcinoma

  • Toh T
  • Lim J
  • Chow E
N/ACitations
Citations of this article
71Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In recent years, large scale genomics and genome‐wide studies using comprehensive genomic tools have reshaped our understanding of cancer evolution and heterogeneity. Hepatocellular carcinoma, being one of the most deadly cancers in the world has been well established as a disease of the genome that harbours a multitude of genetic and epigenetic aberrations during the process of liver carcinogenesis. As such, in depth understanding of the cancer epigenetics in cancer specimens and biopsy can be useful in clinical settings for molecular subclassification, prognosis, and prediction of therapeutic responses. In this review, we present a concise discussion on recent progress in the field of liver cancer epigenetics and some of the current works that contribute to the progress of liver cancer therapeutics.

Cite

CITATION STYLE

APA

Toh, T. B., Lim, J. J., & Chow, E. K. (2019). Epigenetics of hepatocellular carcinoma. Clinical and Translational Medicine, 8(1). https://doi.org/10.1186/s40169-019-0230-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free